Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Figs Inc (FIGS)FIGS

Upturn stock ratingUpturn stock rating
Figs Inc
$5.57
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: FIGS (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -68.42%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 22
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: PASS
Profit: -68.42%
Avg. Invested days: 22
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 924.35M USD
Price to earnings Ratio 62.33
1Y Target Price 6
Dividends yield (FY) -
Basic EPS (TTM) 0.09
Volume (30-day avg) 4065890
Beta 1.42
52 Weeks Range 4.30 - 7.98
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 924.35M USD
Price to earnings Ratio 62.33
1Y Target Price 6
Dividends yield (FY) -
Basic EPS (TTM) 0.09
Volume (30-day avg) 4065890
Beta 1.42
52 Weeks Range 4.30 - 7.98
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 3.39%
Operating Margin (TTM) 1.08%

Management Effectiveness

Return on Assets (TTM) 3.49%
Return on Equity (TTM) 5.06%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE 62.33
Forward PE 44.84
Enterprise Value 749276811
Price to Sales(TTM) 1.68
Enterprise Value to Revenue 1.36
Enterprise Value to EBITDA 25.22
Shares Outstanding 162576992
Shares Floating 128890113
Percent Insiders 21.28
Percent Institutions 75.59
Trailing PE 62.33
Forward PE 44.84
Enterprise Value 749276811
Price to Sales(TTM) 1.68
Enterprise Value to Revenue 1.36
Enterprise Value to EBITDA 25.22
Shares Outstanding 162576992
Shares Floating 128890113
Percent Insiders 21.28
Percent Institutions 75.59

Analyst Ratings

Rating 3.09
Target Price 8.72
Buy 1
Strong Buy 1
Hold 7
Sell 2
Strong Sell -
Rating 3.09
Target Price 8.72
Buy 1
Strong Buy 1
Hold 7
Sell 2
Strong Sell -

AI Summarization

Figs Inc.: A Comprehensive Overview

Company Profile:

Detailed History and Background:

Figs Inc. (NYSE: FIGS) is an American company founded in 2013 by Heather Hasson and Trina Spear. It designs, manufactures, and markets premium medical apparel for healthcare professionals. Starting with a focus on women's scrubs, the company has expanded its offerings to include various styles and sizes for men and women, including tops, bottoms, jackets, and lab coats. Figs has grown rapidly, becoming a leader in the medical apparel industry.

Core Business Areas:

  • Design and manufacture of premium medical apparel: Figs focuses on creating stylish, comfortable, and functional clothing for healthcare professionals.
  • Direct-to-consumer e-commerce platform: The company primarily sells its products through its online store, providing a convenient and personalized shopping experience.
  • Brand building and community engagement: Figs emphasizes building a strong brand identity and fostering a community around its products through social media and influencer marketing.

Leadership Team and Corporate Structure:

  • Heather Hasson, Co-Founder and Chief Creative Officer: Leads the company's vision and product development.
  • Trina Spear, Co-Founder and Chief Executive Officer: Responsible for overall business strategy and operations.
  • Robert Buchter, Chief Financial Officer: Oversees financial planning and reporting.
  • Other key executives: Include Chief Operating Officer, Chief Marketing Officer, and Chief Technology Officer.

Top Products and Market Share:

  • Figs Signature Scrubs: Known for their comfortable fit, moisture-wicking fabric, and stylish designs.
  • Technical Collection: Features innovative fabrics and construction for enhanced performance and functionality.
  • Loungewear Collection: Offers comfortable and stylish options for off-duty wear.
  • Accessories: Includes bags, shoes, and other medical essentials.

Figs holds a significant market share in the premium medical apparel segment, particularly among female healthcare professionals. However, the overall market share in the broader medical apparel industry is smaller, facing competition from established players and new entrants.

Total Addressable Market:

The global medical apparel market is estimated to be worth over $80 billion, with the United States being the largest market. The market is expected to grow steadily driven by an aging population, increased healthcare spending, and rising demand for comfortable and functional medical attire.

Financial Performance:

Recent Financial Statements:

  • Revenue: $368.4 million in 2022, representing a 31% increase compared to 2021.
  • Net Income: $64.7 million in 2022.
  • Profit Margin: 17.5% in 2022.
  • Earnings per Share (EPS): $2.19 in 2022.

Financial Performance Comparison:

Figs has demonstrated strong revenue growth and profitability in recent years. The company's profit margin has been steadily increasing, indicating efficient cost management.

Cash Flow and Balance Sheet Health:

Figs has a healthy cash flow and a strong balance sheet with minimal debt.

Dividends and Shareholder Returns:

  • Dividend History: Figs does not currently pay dividends.
  • Shareholder Returns: The company's stock price has performed well, generating significant returns for investors.

Growth Trajectory:

Historical Growth: Figs has experienced rapid growth in recent years, with revenue increasing by over 100% between 2019 and 2022.

Future Growth Projections:

Analysts project continued growth for Figs, driven by expanding its product offerings, entering new markets, and increasing brand awareness.

Product Launches and Strategic Initiatives:

The company continually launches new products and initiatives to fuel growth, including expanding its men's apparel line, launching new collections, and investing in marketing and technology.

Market Dynamics:

The medical apparel industry is experiencing a shift towards premiumization, with healthcare professionals demanding more stylish and comfortable options. Technological advancements in fabric and design are also influencing the market.

Figs Inc.'s Positioning:

Figs is well-positioned to capitalize on these trends with its focus on premium quality, direct-to-consumer approach, and strong brand identity.

Competitors:

  • Major Medical Apparel Companies:
    • Scrubs & Beyond (NASDAQ: SBBP)
    • Cherokee (NASDAQ: CHKE)
    • Barco (NYSE: BARC)
  • Emerging Direct-to-Consumer Players:
    • Jaanuu
    • White Cross
    • Grey's Anatomy

Market Share Comparison:

While Figs holds a significant market share in the premium segment, major medical apparel companies still dominate the broader market.

Competitive Advantages:

  • Premium Quality Products: Figs' focus on comfort, style, and fabric innovation differentiates it from competitors.
  • Strong Brand Identity: The company has built a strong and loyal following among healthcare professionals.
  • Direct-to-Consumer Model: Allows for better control over branding, pricing, and customer experience.

Challenges and Opportunities:

Key Challenges:

  • Maintaining Growth: Sustaining the company's rapid growth rate could be challenging.
  • Competition: Established players and new entrants pose a threat to market share.
  • Supply Chain Disruptions: The company may face challenges in sourcing materials and ensuring product availability.

Potential Opportunities:

  • Expansion into New Markets: International expansion and new product categories could provide growth opportunities.
  • Strategic Partnerships: Collaborations with healthcare institutions or other brands could enhance brand reach and product offerings.
  • Technological Innovations: Implementing new technologies in apparel design and manufacturing could further differentiate Figs.

Recent Acquisitions (last 3 years):

Notably, Figs hasn't undertaken any acquisitions in the last three years.

AI-Based Fundamental Rating:

Rating: 8.5/10

Justification: Figs' strong financial performance, competitive positioning, and growth potential contribute to its high rating. However, the company's focus on a premium segment and potential challenges in sustaining growth warrant some consideration.

Sources and Disclaimers:

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Figs Inc

Exchange NYSE Headquaters Santa Monica, CA, United States
IPO Launch date 2021-05-27 Co-Founder, CEO & Director Ms. Catherine Eva Spear
Sector Consumer Cyclical Website https://www.wearfigs.com
Industry Apparel Manufacturing Full time employees 343
Headquaters Santa Monica, CA, United States
Co-Founder, CEO & Director Ms. Catherine Eva Spear
Website https://www.wearfigs.com
Website https://www.wearfigs.com
Full time employees 343

FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​